Clascoterone Cream 1% is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial
Journal of Drugs in Dermatology · 2026
DOI: 10.36849/jdd.10040 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Journal of Drugs in Dermatology, 2026. Verfasst von Lucie Joerg und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Rosacea, Skin Cream, Sulfides, Tosyl Compounds.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Joerg, L., Zafar, K., Kabakova, M., Wang, J. Y., Stolyar, J., Zudell, J., & Jagdeo, J. (2026). Clascoterone Cream 1% is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.10040
Vancouver
Joerg L, Zafar K, Kabakova M, Wang JY, Stolyar J, Zudell J, et al. Clascoterone Cream 1% is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial. Journal of Drugs in Dermatology. 2026. doi:10.36849/jdd.10040
BibTeX
@article{Joerg2026,
author = {Joerg, Lucie and Zafar, Kayla and Kabakova, Margaret and Wang, Jennifer Y and Stolyar, Julia and Zudell, Jenna and Jagdeo, Jared},
title = {Clascoterone Cream 1% is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial},
journal = {Journal of Drugs in Dermatology},
year = {2026},
doi = {10.36849/jdd.10040}
}
EUVIMED